Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 3 Algorithm for the determination of the clinical

Published byAllyson Welch Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 3 Algorithm for the determination of the clinical"— Presentation transcript:

1 Figure 3 Algorithm for the determination of the clinical
significance of concomitant prostate cancer diagnosed at RCP Figure 3 | Algorithm for the determination of the clinical significance of concomitant prostate cancer diagnosed at RCP. Patients whose clinical characteristics are similar to those shown in left side of the panel are at risk of having clinically significant prostate cancer and, therefore, require regular follow‑up monitoring, possibly with additional treatment. Patients with at least one of the tumour-specific characteristics of high-risk disease should be considered to have high-risk disease. Patients with clinical characteristics similar to those shown in the right side of the panel have a low risk of clinically significant prostate cancer and, therefore, should receive regular follow‑up monitoring for signs of disease progression. RCP, radical cystoprostatectomy. Lopez-Beltran, A. et al. (2017) Concomitant bladder cancer and prostate cancer: challenges and controversies Nat. Rev. Urol. doi: /nrurol

Download ppt "Figure 3 Algorithm for the determination of the clinical"

Similar presentations

Single immediate postoperative instillation of chemotherapy in patients with Ta/T1 bladder TCC Dr Charles Chabert.

Single immediate postoperative instillation of chemotherapy in patients with Ta/T1 bladder TCC Dr Charles Chabert.
Prostate Cancer: A Case for Active Surveillance Philip Kantoff MD Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School.

Prostate Cancer: A Case for Active Surveillance Philip Kantoff MD Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School.
Prostatectomy operations in England South West Public Health Observatory www.swpho.nhs.uk Trends in the use of radical prostatectomy in England Sean McPhail.

Prostatectomy operations in England South West Public Health Observatory Trends in the use of radical prostatectomy in England Sean McPhail.
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.

Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.
Figure 4 Types of urinary diversion

Figure 4 Types of urinary diversion
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 2 Recruitment of experts to the Delphi study

Figure 2 Recruitment of experts to the Delphi study
Figure 5 Mutational heterogeneity in oesophageal and gastric cancer

Figure 5 Mutational heterogeneity in oesophageal and gastric cancer
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 1 Cellular processes involved in cancer development

Figure 1 Cellular processes involved in cancer development
Figure 3 Birt–Hogg–Dubé (BHD) renal tumour histology

Figure 3 Birt–Hogg–Dubé (BHD) renal tumour histology
Figure 5 Schematic illustration of different clinical trial designs

Figure 5 Schematic illustration of different clinical trial designs
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 3 Semantic model of the active surveillance (AS) timeline

Figure 3 Semantic model of the active surveillance (AS) timeline
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Nat. Rev. Clin. Oncol. doi: /nrclinonc

Nat. Rev. Clin. Oncol. doi: /nrclinonc
Figure 2 Representative images from a right radical

Figure 2 Representative images from a right radical
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Similar presentations

Ads by Google